Study of Coagulation Factor VIIa Variant Marzeptacog Alfa (Activated) in Adult Subjects With Hemophilia A and B
Clinical trial NCT03407651 · COMPLETED
Trial details
- NCT number
- NCT03407651
- Sponsor
- Catalyst Biosciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-12-18
- Primary completion
- 2019-03-15
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.